DIM vs Anastrozole
DIM is a cruciferous-derived metabolite that shifts estrogen metabolism toward favorable 2-hydroxy pathways. Anastrozole is a pharmaceutical aromatase inhibitor. DIM is gentler; anastrozole is potent and reserved for confirmed hyperestrogenemia.
DIM is appropriate as a gentle estrogen-metabolism adjunct in optimization protocols.
Anastrozole is appropriate only when biomarker-confirmed symptomatic high estradiol persists.
Explore pathwayEducational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Can DIM replace anastrozole?
Not for confirmed pathologic hyperestrogenemia.
Is DIM evidence strong?
Mechanistic evidence is reasonable; clinical evidence is modest.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment